Rallis India experienced a significant upswing in its shares, reaching an all-time high of ₹373.80 on the BSE following a robust Q2 FY25 report. The surge of 16.2% was driven by favourable second-quarter results, showcasing a 19.51% increase in net profit to ₹98 crore from ₹82 crore year-on-year.
The company, a subsidiary of Tata Chemicals within the Tata Group, reported an 11.5% increase in revenue to ₹928 crore compared to ₹832 crore in the same quarter last year. This growth was primarily fueled by robust domestic sales in both the crop care and seeds sectors, indicating strong market performance.
Also read: Gen Z Boosts India’s Consumer Spending to $860 Billion !
Internationally, Rallis India saw a recovery in volume, although pricing pressures persisted. Nonetheless, the company is optimistic about the upcoming rabi season, bolstered by higher reservoir water levels, which may enhance agricultural outputs and drive future growth.
Earnings per share also saw an improvement, rising from ₹4.23 in September 2023 to ₹5.04 in the current fiscal quarter. This increase reflects the company’s continued profitability and effective financial management during the period.
Also read: Cochin Shipyard Shares Drop Amid 5% Stake Sale at ₹1,540
As of this report, Rallis India’s shares were trading at ₹367.55, up 14.29%, with a market capitalization of ₹7,147.70 crores. The company remains a key player in the agricultural inputs industry, providing integrated crop management solutions that improve yield and farm income.
In a strategic move to expand its product line, Rallis India launched ‘Mark Plus’, a new herbicide for soybean and groundnut crops, in June 2024. Initially available in Maharashtra, Madhya Pradesh, and Gujarat, the herbicide aims to provide effective weed control by targeting critical growth enzymes in weeds.
